Author’s Reply to Pestana et al. Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”

Afsaneh Alavi, Laura Raffals

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)593-594
Number of pages2
JournalAmerican Journal of Clinical Dermatology
Volume23
Issue number4
DOIs
StatePublished - Jul 2022

ASJC Scopus subject areas

  • Dermatology

Cite this